NO993702L - Frysetörket preparat av humant benmorfogenetisk MP52-protein - Google Patents

Frysetörket preparat av humant benmorfogenetisk MP52-protein

Info

Publication number
NO993702L
NO993702L NO993702A NO993702A NO993702L NO 993702 L NO993702 L NO 993702L NO 993702 A NO993702 A NO 993702A NO 993702 A NO993702 A NO 993702A NO 993702 L NO993702 L NO 993702L
Authority
NO
Norway
Prior art keywords
freeze
protein
bone morphogenetic
human bone
dried preparation
Prior art date
Application number
NO993702A
Other languages
English (en)
Other versions
NO322334B1 (no
NO993702D0 (no
Inventor
Hideki Ichikawa
Mitsuko Inagaki
Original Assignee
Hoechst Marion Roussel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Ltd filed Critical Hoechst Marion Roussel Ltd
Publication of NO993702D0 publication Critical patent/NO993702D0/no
Publication of NO993702L publication Critical patent/NO993702L/no
Publication of NO322334B1 publication Critical patent/NO322334B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19993702A 1997-01-30 1999-07-29 Lyofilisert preparat av human benmorfogenetisk faktor MP52, og fremgangsmate for fremstilling av et lyofilisert preparat av human benmorfogenetisk faktor MP52 NO322334B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1634997 1997-01-30
PCT/JP1998/000371 WO1998033514A1 (en) 1997-01-30 1998-01-29 Freeze-dried composition of bone morphogenetic protein human mp52

Publications (3)

Publication Number Publication Date
NO993702D0 NO993702D0 (no) 1999-07-29
NO993702L true NO993702L (no) 1999-09-29
NO322334B1 NO322334B1 (no) 2006-09-18

Family

ID=11913900

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19993702A NO322334B1 (no) 1997-01-30 1999-07-29 Lyofilisert preparat av human benmorfogenetisk faktor MP52, og fremgangsmate for fremstilling av et lyofilisert preparat av human benmorfogenetisk faktor MP52

Country Status (22)

Country Link
EP (1) EP0972520B9 (no)
JP (1) JP4209948B2 (no)
KR (1) KR100548107B1 (no)
CN (1) CN1152712C (no)
AP (1) AP983A (no)
AT (1) ATE302021T1 (no)
AU (1) AU737595B2 (no)
BR (1) BR9807537B1 (no)
CA (1) CA2278546C (no)
DE (1) DE69831223T9 (no)
DK (1) DK0972520T3 (no)
EA (1) EA001579B1 (no)
ES (1) ES2244043T3 (no)
HU (1) HU226554B1 (no)
IL (2) IL130967A0 (no)
NO (1) NO322334B1 (no)
NZ (1) NZ336509A (no)
PL (1) PL189381B1 (no)
RS (1) RS49691B (no)
SI (1) SI0972520T1 (no)
TR (1) TR199901832T2 (no)
WO (1) WO1998033514A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4388602B2 (ja) † 1997-02-07 2009-12-24 ストライカー コーポレイション マトリクスを含まない骨形成デバイス、移植片、およびその使用方法
WO2003030873A1 (en) * 2001-10-09 2003-04-17 Cellfactors Plc Therapeutic biological product and method for formation of new vascularised bone
ES2247423T5 (es) 2001-11-19 2015-12-30 Scil Technology Gmbh Método de producción de un dispositivo recubierto homogéneamente que tiene propiedades osteoinductoras y osteoconductoras
ATE322916T1 (de) 2002-09-10 2006-04-15 Scil Technology Gmbh Unter verringerter sauerstoffkonzentration mit einem osteoinduktiven protein beschichtetes metallimplantat
EP1651272A1 (en) * 2003-08-05 2006-05-03 Fuji Photo Film B.V. Use of recombinant or synthetic gelatin as a stabiliser in vaccines
EP1685160A1 (en) * 2003-11-10 2006-08-02 Arriva-Prometic Inc. Dry recombinant human alpha 1-antitrypsin formulation
ATE478008T1 (de) 2004-03-10 2010-09-15 Scil Technology Gmbh Überzogene implantate, ihre herstellung und verwendung davon
US20160344677A1 (en) 2015-05-22 2016-11-24 Microsoft Technology Licensing, Llc Unified messaging platform for providing interactive semantic objects
US10216709B2 (en) 2015-05-22 2019-02-26 Microsoft Technology Licensing, Llc Unified messaging platform and interface for providing inline replies

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0080879B1 (en) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Pharmaceutical composition containing interferon in stable state
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
DE69213739T2 (de) * 1991-06-21 1997-02-20 Genetics Institute, Inc., Cambridge, Mass. Osteogene proteine enthaltende arzneimittel
JP2966592B2 (ja) * 1991-07-20 1999-10-25 萩原 義秀 安定化されたヒトモノクローナル抗体製剤
DK0625989T3 (da) * 1992-02-12 2000-06-26 Bioph Biotech Entw Pharm Gmbh DNA-sekvenser kodende for hidtil ukendte vækst-/differentieringsfaktorer
CA2093836A1 (en) * 1992-04-24 1993-10-25 Wayne Gombotz Biodegradable tgf-.beta. delivery system for bone regeneration
DE4239877C1 (de) * 1992-11-27 1994-03-17 Boehringer Ingelheim Int Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung
PT814841E (pt) * 1995-03-21 2002-03-28 Applied Research Systems Formulacoes liquidas de hcg
WO1996033215A1 (en) * 1995-04-19 1996-10-24 Hoechst Pharmaceuticals & Chemicals K.K. Novel protein and process for producing the same

Also Published As

Publication number Publication date
AP9901602A0 (en) 1999-09-30
PL334852A1 (en) 2000-03-27
BR9807537B1 (pt) 2009-01-13
WO1998033514A1 (en) 1998-08-06
AU737595B2 (en) 2001-08-23
NO322334B1 (no) 2006-09-18
EA001579B1 (ru) 2001-06-25
NZ336509A (en) 2001-03-30
JP4209948B2 (ja) 2009-01-14
CN1244127A (zh) 2000-02-09
AU5679198A (en) 1998-08-25
DE69831223D1 (de) 2005-09-22
AP983A (en) 2001-07-16
CA2278546C (en) 2008-04-01
NO993702D0 (no) 1999-07-29
DE69831223T9 (de) 2006-12-07
EP0972520B9 (en) 2006-03-22
PL189381B1 (pl) 2005-07-29
EP0972520B1 (en) 2005-08-17
HU226554B1 (en) 2009-03-30
DK0972520T3 (da) 2005-12-19
TR199901832T2 (xx) 1999-12-21
DE69831223T2 (de) 2006-02-16
EA199900694A1 (ru) 2000-04-24
BR9807537A (pt) 2000-03-21
IL130967A0 (en) 2001-01-28
CN1152712C (zh) 2004-06-09
ATE302021T1 (de) 2005-09-15
CA2278546A1 (en) 1998-08-06
RS49691B (sr) 2007-12-31
IL130967A (en) 2006-12-10
YU34999A (sh) 2002-08-12
SI0972520T1 (sl) 2006-02-28
EP0972520A1 (en) 2000-01-19
HUP0002386A3 (en) 2002-09-30
EP0972520A4 (en) 2002-11-05
ES2244043T3 (es) 2005-12-01
KR100548107B1 (ko) 2006-02-02
HUP0002386A2 (hu) 2000-11-28
KR20000070586A (ko) 2000-11-25

Similar Documents

Publication Publication Date Title
NO995134D0 (no) Forbedrede fremgangsmåter for fremstilling av aktivert protein C
AU3866097A (en) Naphtholactams and lactones as bone morphogenetic protein active agents
ZA989461B (en) Methods and compositions for the treatment of autoimmune disease using heat shock proteins
EP1100869A4 (en) 98 HUMAN SECRETED PROTEINS
EP1088071A4 (en) 94 HUMAN SECRETED PROTEINS
PL339463A1 (en) April - novel protein of growth promoting action
FR2751202B1 (fr) Implant squelettique
NO965208D0 (no) Benprotese
BR9608344A (pt) Formulações de hidroxiapatita biocompatível e usos das mesmas
DE69728408D1 (de) Nichtinvasive abbildung von biologischem gewebe
DE69630933D1 (de) Hohle Knochenprothese mit angepasster Flexibilität
DE69715264D1 (de) Knochenprothese
NO963049D0 (no) Modulatorer av forankrende proteinfunksjon
BR9707151A (pt) Conjunto de aplicação de um produto e conjunto aplicador de um desodorante corporal
PT907364E (pt) Composicao farmaceutica de libertacao sustida
EP1019091A4 (en) 50 SECRETED PROTEINS OF HUMAN ORIGIN
EP0832125A4 (en) Human g-protein receptor hgber32
EP1044211A4 (en) 36 HUMAN SECRETED PROTEINS
EP1124850A4 (en) 12 HUMAN SECRETED PROTEINS
NO993702D0 (no) Frysetörket preparat av humant benmorfogenetisk MP52-protein
FR2767674B1 (fr) Prothese de l'extremite superieure de l'humerus
EP1027430A4 (en) 64 HUMAN SECRETED PROTEINS
EP1062236A4 (en) 31 HUMAN SECRETED PROTEINS
ID23174A (id) Bahan pelumas roda gigi terbuka
ZA983239B (en) Stable active human ob protein compositions and methods

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees